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Summary
Objectives: We hypothesised that osteochondral and synovial angiogenesis in osteoarthritis (OA) are independent processes. We investigated
whether indices of osteochondral and synovial angiogenesis display different relationships with synovitis, disease severity and chondrocalci-
nosis in patients with OA.
Design: Synovium and medial tibial plateaux were obtained from 62 patients undergoing total knee joint replacement for OA (18 [29%] had
chondrocalcinosis) and from 31 recently deceased people with no evidence of joint pathology post-mortem (PM). Vascular endothelium, pro-
liferating endothelial cells (ECs) and macrophages were quantiﬁed by immunohistochemistry for CD34, CD31/Ki67 and CD14, respectively.
Grades were assigned for radiographic and histological OA disease severity, clinical disease activity and histological synovitis (based on
cellular content of the synovium).
Results: Blood vessels breached the tidemark in 60% of patients with OA and 20% of PM controls. Osteochondral vascular density increased
with increasing cartilage severity and clinical disease activity scores, but not with synovitis. Synovial EC proliferation, inﬂammation and mac-
rophage inﬁltration were higher in OA than in PM controls. Synovial angiogenesis indices increased with increasing histological synovitis, but
were not related to osteochondral vascular density or other indices of OA disease severity. OA changes were more severe in patients with
concurrent chondrocalcinosis. Chondrocalcinosis was not associated with increased angiogenesis or histological synovitis beyond that
seen in OA alone.
Conclusion: Osteochondral and synovial angiogenesis appear to be independent processes. Osteochondral vascularity is associated with the
severity of OA cartilage changes and clinical disease activity, whereas synovial angiogenesis is associated with histological synovitis. Mod-
ulation of osteochondral and synovial angiogenesis may differentially affect OA disease.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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OA is an important cause of pain and disability in the ageing
population. Features of osteoarthritis (OA) include cartilage
loss, osteophyte (OST) formation and synovial inﬂamma-
tion. Angiogenesis, the formation of new blood vessels
from pre-existing ones, may contribute to each of these fea-
tures of OA1. Invasion of blood vessels across the osteo-
chondral junction may contribute to articular cartilage
changes in OA by causing cartilage calciﬁcation or ossiﬁca-
tion. Cells present within vascular channels may modulate
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Received 19 July 2006; revision accepted 28 January 2007.7chondrocyte function, and degrade cartilage matrix2,3. Vas-
cular breaching may compromise the normal barrier be-
tween articular cartilage and subchondral bone imparted
by the layer of calciﬁed cartilage. Additionally, OSTs form
by endochondral ossiﬁcation, a process that is believed to
be angiogenesis-dependent. Furthermore, angiogenesis is
a key component of chronic inﬂammation, and inhibition of
angiogenesis can inhibit synovitis in vivo4. Synovitis may
contribute not only to symptoms in OA, but through the gen-
eration of cytokines and low molecular weight factors, may
further impair chondrocyte function and homeostasis of the
articular cartilage5,6.
The synovium plays a key role in maintaining healthy ar-
ticular cartilage, and cartilage may modulate the function of
the adjacent synovium7. The synovium and articular carti-
lage are in close proximity and there is a free ﬂow of solutes
between the two, raising the possibility that osteochondral
and synovial angiogenesis are driven by common mecha-
nisms. On the other hand, angiogenesis can be driven by
a wide variety of factors in different tissues, raising the43
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giogenesis are parallel, but differentially regulated pro-
cesses in OA. Synovial angiogenesis has been linked to
histological synovitis, in particular macrophage inﬁltration
of the synovium8. In addition, changes in articular cartilage
may also modulate angiogenic activity through alterations in
the matrix composition and expression and release of an-
giogenic factors9,10. Determining the relative contributions
of synovitis and cartilage changes to angiogenesis within
the joint, therefore requires concurrent assessment of the
complex tissues of several joint compartments.
Chondrocalcinosis (CC) results from the deposition of
calcium crystals, including calcium pyrophosphate dihy-
drate (CPPD), in articular and meniscal cartilages, and is of-
ten associated with OA. Radiographically apparent CC is
associated with higher grades of radiographic OA sever-
ity11. CC can be associated with episodes of pseudogout,
where CPPD crystals stimulate synovial ﬂuid leukocytes,
thereby causing severe acute inﬂammation. It is unknown,
however, whether CC is an important cause of subclinical
chronic synovitis or angiogenesis in patients with OA.
We have investigated the relationship between indices of
angiogenesis in the synovium and the articular cartilage to
assess whether a common mechanism may explain both.
We also determined whether synovial and osteochondral
angiogenesis could be explained by histological, radio-
graphic or clinical evidence of severity, activity or subtype
of OA disease.
Patients and methods
PATIENTS
Tissue samples were obtained from a repository of joint
tissues and matched clinical data. Informed consent was
gained from each donor or next of kin (post-mortem [PM]
cases) according to protocols approved by the North Not-
tinghamshire Research Ethics Committee and Nottingham
Research Ethics Committee 1 (Projects NNHA/420, NNHA/
544, NNHA/673 and 05/Q2403/24)12. Synovium and medial
tibial plateaux were obtained from patients undergoing total
knee joint replacement surgery for OA, all of whom fulﬁlled
the American College of Rheumatology revised criteria for
the diagnosis of knee OA13. Patients with RA and other
arthritides were excluded from the study. Samples of medial
tibial plateaux represented the total number held in the
repository from patients undergoing total knee replacement
for OA at the time of the study (n¼ 45), excluding samples
where no articular cartilage was present (n¼ 8). Five (11%)
of the 45 included patients had radiographic CC. Matched
synovia from these cases were supplemented from an addi-
tional 19 cases, sampled purposively from the repository to
create a larger cohort with increased power for subgroup
analysis, classiﬁed as OA with CC (OA/CCþ; n¼ 18, 12
males) or OA without CC (OA/CC; n¼ 44, 26 females)
based on the deﬁnite presence or absence of radiographic
meniscal calciﬁcation in the affected knee. Synovium and
medial tibial plateaux from a further 31 patients (one knee
each) were collected at post-mortem examination (PM)
from people with no history of OA or other rheumatic prob-
lems, as a normal control group (n¼ 31, 19 males). Medical
records, history from the next of kin and clinical examination
of PM patients were used to exclude cases with any clinical
evidence of OA. PM cases were excluded if there was
evidence of Heberden’s/Bouchard’s nodes, history of
pain, fracture or previous surgery to the knee, or if the
articular surfaces displayed OSTs or macroscopic evidenceof OA more severe than surface ﬁbrillation. Osteochondral
histomorphometry and cartilage scoring was performed
on 36 OC/CC samples, seven OA/CCþ samples and 14
PM samples. Synovial histomorphometry was performed
on samples from 25 OA/CC, 14 OA/CCþ and 16 PM
cases.
CLINICAL ASSESSMENT
Clinical disease activity scores were calculated for pa-
tients undergoing total knee replacement14. This system
uses six clinical parameters related to the operated knee
(joint line tenderness, morning stiffness, inactivity stiffness,
increased temperature, effusion, and soft tissue swelling).
RADIOGRAPHIC CLASSIFICATION AND SCORING
Pre-operative postero-anterior knee radiographs from
patients with OA were examined by at least two indepen-
dent observers including one consultant rheumatologist,
all of whom were blinded to patient details and histological
ﬁndings. Radiographs were not available for PM cases. Mis-
classiﬁcation of CC status was minimised by excluding
doubtful cases and those where joint space narrowing
(JSN) was so severe that no space was visible in the medial
tibiofemoral compartment. JSN and OST scores were as-
signed to each case using a line drawing atlas15. Scores
for medial and lateral tibiofemoral compartments were sum-
mated to give total JSN and total OST scores.
SAMPLE COLLECTION AND PROCESSING
Samples were ﬁxed in neutral-buffered formalin and then
wax embedded (tibial plateaux) or mounted unﬁxed in OCT
in melting isopentane and stored at 70C (synovium). Mid-
coronal sections of medial tibial plateaux were decalciﬁed in
10% ethylenediaminetetraacetic acid and 10 mM Tris buffer
(pH 6.95) at room temperature prior to wax embedding.
HISTOLOGY AND GRADING
Sections (5 mm) of medial tibial plateau were stained with
safranin-O. Following nuclear staining with Weigert’s hae-
matoxylin (2 min) and differentiation in acid alcohol (15 s),
sections were immersed in 0.02% fast green FCF (Sigma,
Poole, UK), then 0.1% safranin-O (Sigma) for 1 min and
mounted in DePeX mounting medium. Grades for the se-
verity of OA changes in the articular cartilage (cartilage
score) were the sum of four components; cartilage surface
integrity (grade 0 [normal] to 6 (complete disorganisation)),
chondrocyte appearance (0 [normal] to 3 [hypocellularity]),
proteoglycan loss (0 [no loss of safranin-O stain] to 4 [ab-
sence of staining]) and tidemark integrity (0 [intact] or 1
[crossed by blood vessels])16.
Synovium sections (5 mm) were stained with haematoxy-
lin and eosin and graded 0e3 (normal to severe inﬂamma-
tion) according to lining cell depth, hypercellularity and
lymphocyte inﬁltration8.
IMMUNOHISTOCHEMISTRY
Blood vessels at the osteochondral junction of the medial
tibial plateau were visualised using monoclonal anti-CD34
antibody and an avidinebiotin complex (ABC)-alkaline
phosphatase technique with Fast Red. Osteochondral
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nated by autoﬂuorescence.
Synovial samples with intimal lining present were used for
immunohistochemistry. Double sequential immunohisto-
chemistry was performed as previously described to visual-
ise proliferating endothelial cells (ECs) in the synovium8.
Brieﬂy, proliferating cell nuclei were visualised using
a monoclonal anti-Ki67 antigen antibody and a nickel-
enhanced ABC-peroxidase technique; while ECs were
visualised with a monoclonal anti-CD31 (PECAM-1) antibody
and an ABC-alkaline phosphatase technique with Fast
Red. Sections were counter-stained with 40e60-diami-
dino-2-phenylindole to visualise Ki67-negative nuclei. Mac-
rophages were visualised using a monoclonal anti-CD14
antibody and an ABC-peroxidase technique developed
with diaminobenzidine8. All antibodies were prepared in
buffers containing 0.05% bovine serum albumen and
0.03% horse serum.
IMAGE ANALYSIS
All image analysis was carried out using a Zeiss Axio-
skop-50 microscope with a 20 objective lens (Carl Zeiss
Ltd, Welwyn Garden City, UK). Osteochondral vascular den-
sity was measured as the number of vascular channels with
CD34 immunoreactivity within the non-calciﬁed cartilage
determined across seven adjacent ﬁelds of view (w7 mm)
centred on the mid point of the medial tibial plateau. For
synovial samples, transmitted light and ﬂuorescence images
within 200 mmof the synovial surface were captured for each
ﬁeld using a video camera module and analysed using
a KS300 image analysis system (Imaging Associates,
Bicester, UK). CD31-immunoreactive blood vessels were
thresholded and interactively included based on morphology.
Indices for EC fractional areas, EC proliferation and macro-
phage inﬁltration were derived as previously described8.
STATISTICAL ANALYSIS
Data were analysed using SPSS software, version 11
(Chicago, IL, USA). ManneWhitney U-test was used to
compare data from all patients with OA and PM controls,
then post hoc comparisons between OA/CCþ and OA/
CC subgroups. c2 statistic was used to compare frequen-
cies of tidemark breaching between OA and PM. Possible
associations between variables are expressed as Spear-
man’s rank correlation coefﬁcients, unless stated as partial
correlation coefﬁcients. P< 0.05 after correction for multiple
comparisons was taken to indicate statistical signiﬁcance.
Data are presented as median and interquartile range
(IQR).
MATERIALS
Monoclonal mouse anti- Ki-67 antigen antibody (clone
MIB-5) and monoclonal mouse anti-CD34 antibody (clone
QBEnd10) were obtained from DakoCytomation, Cam-
bridge, UK. Monoclonal mouse anti-CD31 antibody (clone
TLD-3A12) was from Serotec, Oxford, UK. Biotinylated
rat-adsorbed horse anti-mouse antibody, Vectastain ABC-
peroxidase Elite and ABC-alkaline phosphatase kits were
obtained from Vector Laboratories Ltd., Peterborough, UK.
Mayer’s haematoxylin, eosin and TissueTek mounting
medium were obtained from Raymond A. Lamb Ltd., East-
bourne, East Sussex, UK. Ammonium chloride, DePeX
mounting medium, Superfrost Plus microscope slides,phosphate buffered saline (pH 7.5), ethanol and xylene
were from WVR International Ltd., Poole, UK. Orthophos-
phate buffered formalin was from Cell Path PLC, Newtown
Powys, Wales, UK. Monoclonal anti-CD14 (clone UCHM-1)
and all other chemicals and reagents were from Sigma
Chemical Co., Poole, UK.
Results
Vascular breaching of the tidemark in the medial tibial
plateau was observed mostly in patients with OA
[Fig. 1(AeF)]. Fibrovascular tissue, including CD34-
immunoreactive vascular endothelium, crossed from the
subchondral bone, through the calciﬁed layer of cartilage
and breached the deepest tidemark in 27/45 (60%) patients
diagnosed with OA and 2/10 (20%) PM controls (c2¼ 5.6,
P¼ 0.02). These osteochondral vessels occurred in regions
with low proteoglycan density, as revealed by loss of safra-
nin-O staining [Fig. 1(EeF)]. Vascular density in the non-
calciﬁed articular cartilage at the osteochondral junction
was higher in patients with OA than in PM controls
[Fig. 2(A)].
Vascular density at the osteochondral junction increased
with increasing OA disease severity (Fig. 3). Osteochondral
vascular density increased with histological cartilage sever-
ity score [Fig. 3(A)]. Partial correlation coefﬁcients revealed
that vascular density in the non-calciﬁed cartilage increased
with increasing total cartilage severity score independent of
diagnostic group (r¼ 0.38, P¼ 0.005). Partial correlation
coefﬁcients calculated for individual components of the car-
tilage score indicated that vascular density at the osteo-
chondral junction increased with decreasing cartilage
surface integrity (r¼ 0.31, P¼ 0.018), more abnormal chon-
drocyte appearance (r¼ 0.39, P¼ 0.002) and greater pro-
teoglycan loss (r¼ 0.53, P< 0.001), each independent of
tidemark integrity score. High osteochondral vascular den-
sities were associated also with high clinical disease activity
scores [Fig. 3(D)]. Vascular densities in the articular carti-
lage were not signiﬁcantly associated with histological
synovitis scores [Fig. 4(A, D)].
The EC proliferation and macrophage inﬁltration indices
and inﬂammation scores were higher in synovia from pa-
tients with OA than in PM [Figs. 1(G, H), 2(B, H, I)]. Synovial
EC proliferation increased with increasing synovial EC frac-
tional area (r¼ 0.35, P¼ 0.009), macrophage inﬁltration
[Fig. 4(E)] and inﬂammation grade [Fig. 4(B)]. Synovial EC
fractional area and macrophage inﬁltration each increased
with increasing inﬂammation grade [Fig. 4(C) and r¼ 0.46,
P¼ 0.001, respectively]. Partial correlation coefﬁcients re-
vealed that synovial EC proliferation increased with increas-
ing macrophage inﬁltration and inﬂammation grade
independent of diagnosis (r¼ 0.43, P¼ 0.002 and
r¼ 0.37, P¼ 0.01 respectively). Angiogenesis indices in
the synovium were not signiﬁcantly associated with osteo-
chondral vascular density [Fig. 5(A, B)], cartilage or radio-
graphic severity scores, nor with clinical disease activity
scores (Table I). Likewise, inﬂammatory indices in the syno-
vium were not signiﬁcantly associated with JSN, OST or
clinical disease activity scores (data not shown).
OST scores were slightly higher in OA/CCþ than OA/
CC [Fig. 2(F)]. No qualitative or quantitative differences
in osteochondral or synovial angiogenesis, histological sy-
novitis, cartilage severity or clinical disease activity scores
were observed between OA/CCþ and OA/CC cases
[Fig. 2(AeE, GeI)].
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747Osteoarthritis and Cartilage Vol. 15, No. 7Fig. 1. Vascularisation of non-calciﬁed cartilage and synovium in OA compared with PM controls. (A) Vascular channel surrounded by a bone
cuff breaching the tidemark and entering the non-calciﬁed cartilage in a patient with OA. Note duplication of tidemark. (B) Vascular channel in
the calciﬁed cartilage of a PM control. (C, D) CD34-positive ECs (red ﬂuorescence) within vascular channels of preparations shown in A & B
respectively. (E) Vascular channel breaching the tidemark in another patient with OA, showing bone cuff (green) and adjacent depleted pro-
teoglycan (loss of pink stain). (F) Vascular channel within the calciﬁed cartilage of a PM control. (G) CD31-immunoreactive endothelium (red)
displaying proliferating nuclei (black) in synovium from a patient with OA. Note the abnormally high vascularity distant from the synovial lining.
(H) Synovium from a PM control displaying the normal high density of vessels adjacent to the synovial lining, but few Ki67-positive proliferating
nuclei. (A, B) Autoﬂuorescent images under ultraviolet light. (C, D) Red immunoﬂuorescence for CD34. (E, F) Safranin-O and fast green stain.
(G, H) Double sequential immunohistochemsitry for CD31 (red) and Ki67 antigen (black). NCC: non-calciﬁed cartilage, CC: calciﬁed cartilage,
Bo: bone. Short arrows indicate tidemarks. *Indicates vessel lumen. Long arrows indicate proliferating nuclei within ECs. Arrowheads indicate
synovial lining. Scale bars are 100 mm.
Fig. 2. Angiogenesis, radiological, clinical and inﬂammation indices compared between patients with OA and PM controls, alongside
subgroups of OA with and without CC. (A) Osteochondral vascular density in the non-calciﬁed articular cartilage was higher in pa-
tients with OA (median¼ 0.13, IQR 0.0e0.25) than PM controls (median¼ 0.0, IQR 0.0e0.03) (Z¼2.1, P¼ 0.03). (B) Synovial EC
proliferation was higher in patients with OA (median 2.2%, IQR 1.0e5.8%) than in PM (median 0.1%, IQR 0.0e0.7%) (Z¼4.7,
P< 0.001). (C) Synovial vascular densities were similar in all disease groups. (D) Histological cartilage severity score was higher
in OA (median 7, IQR 6e9.3) than in PM controls (median¼ 5.0, IQR 3.5e6.5) (Z¼3.4, P¼ 0.001). (EeG) JSN, OST and clinical
disease activity scores in surgical samples. OST score was higher in osteoarthritic patients with CC (median¼ 8, IQR 5.8e10) than
in those without CC (median¼ 8, IQR 4e8) (Z¼2.0, P¼ 0.045). (H) Macrophage inﬁltration was higher in OA (median¼ 9.7%, IQR
6.3e13.0%) than PM controls (median¼ 4.3%, IQR 2.3e5.3%) (Z¼3.7, P< 0.001) (I) Inﬂammation grade was higher in patients
with OA (median¼ 2, IQR 1e3) than PM controls (median¼ 0, IQR 0e1) (Z¼5.1, P< 0.001). Angiogenesis, clinical and inﬂamma-
tion indices in OA did not differ signiﬁcantly between patients with and those without CC. Box and whisker plots showing median,
IQR and range.
748 D. A. Walsh et al.: Angiogenesis in OAFig. 3. Osteochondral vascularisation and histological, radiological and clinical OA scores. (A) Osteochondral vascular density increased with
increasing histological cartilage score (r¼ 0.26, P¼ 0.049). (B, C) Associations between osteochondral vascular density and radiological OA
severity (JSN and OST scores) did not reach statistical signiﬁcance. (D) Osteochondral vascular density increased with increasing clinical
score (r¼ 0.41, P¼ 0.009). Scatter plots of data from patients with OA (B) and PM controls (:).Discussion
We found that synovial and osteochondral angiogenesis
are both features of OA that occur in parallel. Indices of an-
giogenesis in the synovium were associated with histologi-
cal synovitis but not cartilage changes, whereas vascular
density at the osteochondral junction was associated with
OA changes in the cartilage but not with histological
synovitis.
Previous studies of angiogenesis and inﬂammation in OA
have been limited by difﬁculties in deﬁning disease-free
control groups. The PM group in this study was selected
to exclude, as far as possible, patients with evidence of
OA (or other arthritides). Exclusion criteria for the PM con-
trol group included macroscopic appearance of OA, regular
mild analgesic use, previous visits to a doctor or hospital
about knee pain and previous trauma or surgery to the
knee joint. However, mild or preclinical OA still cannot be
deﬁnitively excluded in the PM group. The observed range
of histological cartilage severity scores (2e7) in the PM
group may represent mild OA, or may represent appear-
ances of normal adult human articular cartilage17. Although
they may occur to a lesser degree sometimes in normal
knees, increased osteochondral vascularity and synovial
EC proliferation, and greater histological synovitis in OA
rather than PM cases, indicate that angiogenesis and
inﬂammation are increased in OA.
CC, in the absence of a current episode of pseudogout,
did not explain angiogenesis either in the synovium or at
the osteochondral junction. Indeed, CC did not appear tobe the major determinant of histological synovitis in OA.
Despite the well known acute pro-inﬂammatory actions
of CPPD crystals, other factors may be more important
determinants of histological synovitis in OA. Our data
are consistent with previous ﬁndings that CC is associated
with more severe radiological change in patients with
OA11. CC therefore may indicate a discrete subset of
the broad spectrum of conditions termed OA18, however,
very large case numbers would be required to discrimi-
nate a unique effect of synovitis or vascularisation in
this subgroup of OA.
Osteochondral vascularity was associated with higher
clinical disease activity scores, indicating that vascularisa-
tion of the articular cartilage may contribute to clinical
features of OA. Vascular invasion may contribute to symp-
toms by facilitating sensory nerve growth into the normally
aneural articular cartilage19. Further work is required to
conﬁrm and explain this apparent association.
The distinct associations of angiogenesis at the osteo-
chondral junction and in synovium respectively may indi-
cate that different mechanisms drive vascular growth in
these two tissues in OA. It remains possible that synovitis
and cartilage changes more weakly contribute to angio-
genesis in the adjacent tissue, but local factors within
the tissue seem most important. Our ﬁndings indicate
that future studies of synovial angiogenesis should focus
on factors produced by the inﬂamed synovium, whereas
studies of osteochondral angiogenesis should address
changes in cartilage matrix composition and chondrocyte
function.
749Osteoarthritis and Cartilage Vol. 15, No. 7Fig. 4. Osteochondral and synovial vascularisation and synovial inﬂammation. (A, D) Osteochondral vascular density was not signiﬁcantly as-
sociated with synovial inﬂammation grade (A) or synovial macrophage inﬁltration (D). (B, E) Synovial EC proliferation increased with increas-
ing inﬂammation grade (B, r¼ 0.59, P< 0.001), and with increasing synovial macrophage inﬁltration (E, r¼ 0.54, P< 0.001). (C) Synovial
EC fractional area increased with increasing inﬂammation grade (C, r¼ 0.42, P¼ 0.002). (F) Synovial EC fractional area vs macrophage
inﬁltration. Scatter plots of data from patients with OA (B) and PM controls (:).Several factors produced by resident and inﬁltrating cells
(such as macrophages1, lymphocytes20 and mast cells21,22)
may contribute to angiogenesis in the inﬂamed synovium.
Of these, vascular endothelial growth factor (VEGF) and
its inducer hypoxia-inducible factor-1a have been associ-
ated with synovial angiogenesis in OA8,23. A large variety
of other angiogenic regulators, both positive and negative,
may also be present in the synovium1. Chondrocytes ex-
pressing VEGF also are increased in articular cartilage
from patients with OA, although their predominantly super-
ﬁcial localisation, distant from the osteochondral junction
may suggest that other factors are more important in its vas-
cular invasion9.The association of vascular channels with regions of pro-
teoglycan loss supports the view that changes in cartilage
matrix may be important in permitting invasion of the articu-
lar cartilage by blood vessels. Loss of resistance to vascular
invasion has been associated with proteoglycan loss in ex-
plant studies using OA articular cartilage3,9.
Angiogenesis in OA may contribute to both symptoms
and disease progression. Vascular growth at the osteo-
chondral junction may contribute to clinical disease activity,
and in the synovium to chronic synovitis. Blood vessel
growth into the articular cartilage may contribute to its ossi-
ﬁcation and to cartilage damage. Novel therapies to manip-
ulate angiogenesis may have potential to relieve theFig. 5. Osteochondral and synovial vascularisation. Osteochondral vascular density was not signiﬁcantly associated with synovial EC prolif-
eration (A) and synovial EC fractional area (B). Scatter plots of data from patients with OA (B) and PM controls (:).
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Synovial and osteochondral angiogenesis indices associated with synovial inflammation and severity of osteoarthritic cartilage changes.
Partial correlation coefficients, controlling for OA or PM status are shown
Synovium Cartilage
EC fractional
area
Inﬂammation
grade
Macrophage
inﬁltration
Osteochondral
vascular density
Cartilage
score
Synovium EC proliferation 0.21 0.33* 0.41** 0.05 0.15
EC fractional area 0.42** 0.10 0.07 0.15
Inﬂammation grade 0.21 0.04 0.17
Macrophage inﬁltration 0.19 0.04
Cartilage Osteochondral vascular density 0.40**
*P< 0.05, **P< 0.01.symptoms and severity of OA by limiting these processes.
Such therapies may need to target common mechanisms
of angiogenesis, or to separately address the factors that
drive vessel growth in the different tissues of the joint. Fur-
ther work is required to elucidate the diverse mechanisms of
angiogenesis that contribute to OA, and the consequences
that inhibiting vessel growth may have on the disease.
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